52North
Cambridge, England, United Kingdom · Biotechnology, Health Care, Medical
52North is a UK med-tech startup focused on oncological advancements. The company offers innovative solutions such as Neutrocheck®, a point-of-care device designed to monitor patients undergoing chemotherapy. With the goal of improving patient care, 52North aims to leverage AI and collaborations to enhance acute oncology care delivery. Their ongoing efforts are supported by strategic partners and
Key facts
- Headquarters
- Cambridge, England, United Kingdom
- Employees
- 14
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- 52north.health
- Company page
Recent activity at 52North
52North funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Funding Round | $6.0M |
Leadership
- Mireia Crispin, Chief Digital Officer
- Ama Frimpong, Head of Product Development
- Umaima Malik Ahmad, Founder
Verified email and direct lines for 52North’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
52North in the news
- Teachers at more than 50 NC schools will walk out Wednesday. Parents, be ready. - Raleigh News & Observer (Jan 08, 2026)
- 52North raises £3.2 million to transform urgent cancer care, with funding co-led by Macmillan Cancer Support and Hargreave Hale AIM VCT - IFA Magazine (Sep 29, 2026)
- Low-cost device being developed to help cancer patients manage their care - University of Cambridge (May 05, 2022)
- 52 North Health raises £1m to progress NeutroCheck device with app - Cambridge Independent (May 09, 2022)
- Caring for cancer patients - University of Cambridge (Jan 31, 2024)
Companies similar to 52North
- Moberg Analytics · Biotechnology, Health Care, Medical, Medical Device
- NanoVibronix · Biotechnology, Health Care, Medical, Medical Device
- SpineCorporation · Biotechnology, Health Care, Medical, Medical Device
- Planatome · Biotechnology, Health Care, Medical, Medical Device
- FesariusTherapeutics · Biotechnology, Health Care, Medical, Medical Device
About 52North: questions and answers
What does 52North do?
52North is a UK med-tech startup focused on oncological advancements. The company offers innovative solutions such as Neutrocheck®, a point-of-care device designed to monitor patients undergoing chemotherapy. With the goal of improving patient care, 52North aims to leverage AI and collaborations to enhance acute oncology care delivery. Their ongoing efforts are supported by strategic partners and
Where is 52North headquartered?
52North is headquartered in Cambridge, England, United Kingdom.
How many employees does 52North have?
52North has about 14 employees.
Has 52North raised funding?
Yes. Fundz has recorded 1 funding event for 52North. The most recent, Funding Round of $6.0M, was in Dec 2024.
Who leads 52North?
Umaima Malik Ahmad is a Founder at 52North.
What is the latest news on 52North?
On Dec 03, 2024, 52North raised €6 million in a funding round co-led by KHP Ventures and Cedars-Sinai IP Co. to advance oncology-focused innovations and bring Neutrocheck® to market.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy